Rectal Cancer Patients Clinical Trials

32 clinical trials for Rectal Cancer Patients across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Single-port Versus Multi-port Robotic Surgery for Rectal Cancer — RECRUITING · NA
• Oncolytic Virotherapy to Enhance PReoperative IMmunotherapy Efficacy in Patients With Proficient Mismatch Repair (pMMR) Rectal Cancer — RECRUITING · PHASE1
• Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery — RECRUITING · PHASE2
• Transanal Total Mesorectal Excision vs Robotic Total Mesorectal Excision — RECRUITING · NA
• Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression — RECRUITING · PHASE2
• Evaluation of Gynecological and Sexual Sequelae — RECRUITING
• Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC. — RECRUITING · PHASE2
• Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial — RECRUITING · PHASE3
• Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer（CONTROL-01） — RECRUITING · PHASE2
• Selective Total Mesorectal Excision Based on Intra-Operative Frozen Section From Local Excision in Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy — RECRUITING · NA
• SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC — RECRUITING · PHASE2
• Rectal Cancer CTC Trial — RECRUITING · NA
• The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study — RECRUITING
• To Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients. — RECRUITING · PHASE2
• Role of Serial C-reactive Protein Concentration Analysis With Computed Tomography in Limiting the Need for Protective Defunctioning Ileostomy After Laparoscopic Low Anterior Resection - A Prospective Study — COMPLETED · NA
• SCARLET - Italian proSpeCtionAl obseRvationaL multicEntre Study on Treatment for recTal pT1 Cancer — NOT_YET_RECRUITING
• Long-Course Concurrent Chemoradiotherapy With Adebrelimab and Apatinib as Neoadjuvant Therapy for Locally Advanced/Low-Lying Rectal Cancer Requiring Sphincter Preservation — ACTIVE_NOT_RECRUITING · PHASE2
• Short-course Radiotherapy Combined With Retlirafusp Alfa and CAPOX Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Prospective, Single-arm, Phase II Clinical Study — ACTIVE_NOT_RECRUITING · PHASE2
• Nodal Downstaging Versus Primary Tumor Regression as Predictors of Survival After Total Neoadjuvant Therapy for Rectal Cancer: A Retrospective Study — NOT_YET_RECRUITING
• Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor Excision — ACTIVE_NOT_RECRUITING · NA
• Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer — NOT_YET_RECRUITING · PHASE2
• Postoperative Outcomes of Single-stapled Anastomosis Combined With Transanal Natural Orifice Specimen Extraction — NOT_YET_RECRUITING
• Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer — NOT_YET_RECRUITING · PHASE2
• Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC — NOT_YET_RECRUITING · PHASE2
• Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer — NOT_YET_RECRUITING · PHASE2
• Study of Intramural Spread Pattern in Low Rectal Cancer. — COMPLETED
• Single-port Robotic Transanal Total Mesorectal Excision — COMPLETED · NA
• Impact Of Metformin In Rectal Cancer Patients — COMPLETED · PHASE2
• Walking and Sitting Difficulties After Rectal Cancer Surgery — NOT_YET_RECRUITING · NA
• Validation of the French Version of the Low Anterior Resection Syndrome (LARS) Among Rectal Cancer Patients — OTHER
• Validation of the Moroccan Arabic Version of the Low Anterior Resection Syndrome (LARS) and Wexner Score of Continence Among Rectal Cancer Patients — COMPLETED
• DCE-MRI PET Bevacizumab Study in Rectal Cancer — WITHDRAWN · PHASE2

Refine this search